Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GFER | P55789 | 1/20 | 0.54 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | MAOB | P27338 | 4/20 | 0.46 |
| ▸ | MAOA | P21397 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.41 |
| ▸ | KCNJ1 | P48048 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA6 | P23280 | 1/20 | 0.39 |
| ▸ | CA5A | P35218 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17541809 | 0.89 | TSHR (0.46) | ALDH1A1TSHRCYP3A4TDP1LOXL2 | |
| SCHEMBL188308 | 0.78 | TSHR (0.64) | ALDH1A1TSHRLOXL2KCNJ1KCNH2 | |
| SCHEMBL19396004 | 0.78 | CA2 (0.48) | ALDH1A1TSHRKCNJ1KCNH2CA2 | |
| SCHEMBL509535 | 0.78 | TAAR1 (0.46) | ALDH1A1TSHRCYP19A1KCNJ1KCNH2 | |
| SCHEMBL2441925 | 0.78 | ACHE (0.46) | ALDH1A1TSHRTDP1KCNJ1KCNH2 | |
| SCHEMBL19396020 | 0.78 | TAAR1 (0.46) | ALDH1A1TSHRTDP1KCNJ1KCNH2 | |
| SCHEMBL4543334 | 0.78 | ESR1 (0.54) | ALDH1A1TSHRCYP3A4TDP1CA2 | |
| SCHEMBL2440720 | 0.78 | CYP1A2 (0.47) | MAOBALDH1A1TSHRMEN1MAPT | |
| SCHEMBL12708608 | 0.78 | TSHR (0.48) | ALDH1A1TSHRCYP3A4TDP1LOXL2 | |
| SCHEMBL9810055 | 0.78 | KCNJ1 (0.53) | MAOBALDH1A1TSHRLOXL2KCNJ1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1086060-B1 | HYDRAZINIUM NITROFORMATE BASED HIGH PERFORMANCE SOLID PROPELLANTS | NL ORGANISATIE VOORTOEGEPAST N (NL) | 2004-11-10 | — | — | EP | claimed |
| EP-1086060-A1 | HYDRAZINIUM NITROFORMATE BASED HIGH PERFORMANCE SOLID PROPELLANTS | NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) | 2001-03-28 | — | — | EP | claimed |
| WO-1999059940-A1 | HYDRAZINIUM NITROFORMATE BASED HIGH PERFORMANCE SOLID PROPELLANTS | NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPIJK ONDERZOEK TNO (NL) | 1999-11-25 | — | — | WO | claimed |
| US-12617738-B2 | Removing dissolved gasses from propellant compositions | GOODRICH CORPORATION (US) | 2026-05-05 | — | — | US | disclosed |
| US-20230250038-A1 | REMOVING DISSOLVED GASSES FROM PROPELLANT COMPOSITIONS | GOODRICH CORPORATION | 2023-08-10 | — | — | US | disclosed |
| EP-3137440-B1 | BONDING AGENTS FOR NITROGEN-CONTAINING OXIDIZERS | RAYTHEON CO (US) | 2021-01-20 | — | — | EP | disclosed |
| EP-3230235-B1 | FERROCENYL BONDING AGENT OXIDIZERS | RAYTHEON CO (US) | 2019-08-21 | — | — | EP | disclosed |
| US-10227267-B2 | Bonding agents for nitrogen-containing oxidizers | RAYTHEON COMPANY (US) | 2019-03-12 | — | — | US | disclosed |
| US-10196324-B2 | Ferrocenyl bonding agent oxidizers | RAYTHEON COMPANY (US) | 2019-02-05 | — | — | US | disclosed |
| EP-3137438-B1 | METHODS TO DESENSITIZE HYDRAZINIUM NITROFORMATE (HNF) | RAYTHEON CO (US) | 2018-09-12 | — | — | EP | disclosed |
| EP-3230235-A1 | FERROCENYL BONDING AGENT OXIDIZERS | Raytheon Company (US) | 2017-10-18 | — | — | EP | disclosed |
| US-6750335-B2 | NUCLEOSIDE FOR USE IN THE GENERATION OF PREFERENTIAL OLIGONUCEOTIDES | NIGU CHEMIE GMBH (DE) | 2004-06-15 | — | — | US | disclosed |
| WO-2004037807-A2 | MEDICINAL ARYLETHANOLAMINE COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2004-05-06 | — | — | WO | disclosed |
| EP-1224198-B1 | NUCLEOSIDE DERIVATIVES WITH PHOTOLABILE PROTECTING GROUPS | NIGU CHEMIE GMBH (DE) | 2003-04-23 | — | — | EP | disclosed |
| US-20020146737-A1 | Nucleoside derivatives with photolabile protective groups | NIGU CHEMIE GMBH (DE) | 2002-10-10 | — | — | US | disclosed |
| EP-1224198-A1 | NUCLEOSIDE DERIVATIVES WITH PHOTOLABILE PROTECTING GROUPS | NIGU CHEMIE GMBH (DE) | 2002-07-24 | — | — | EP | disclosed |
| WO-2001032671-A1 | NUCLEOSIDE DERIVATIVES WITH PHOTOLABILE PROTECTING GROUPS | NIGU CHEMIE GMBH (DE) | 2001-05-10 | — | — | WO | disclosed |
| EP-1086060-A1 | HYDRAZINIUM NITROFORMATE BASED HIGH PERFORMANCE SOLID PROPELLANTS | NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) | 2001-03-28 | — | — | EP | disclosed |
| WO-1999059940-A1 | HYDRAZINIUM NITROFORMATE BASED HIGH PERFORMANCE SOLID PROPELLANTS | NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPIJK ONDERZOEK TNO (NL) | 1999-11-25 | — | — | WO | disclosed |
| EP-0959058-A1 | Hydrazinium nitroformate based high performance solid propellants | NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) | 1999-11-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12617738-B2 | Removing dissolved gasses from propellant compositions | GCN1, CNPY3, GIGYF2 | GFER 217/4885RECQL 1111/4885MAOB 4661/4885 |
| US-20020146737-A1 | Nucleoside derivatives with photolabile protective groups | XRN2, XPA, NSUN2 | GFER 4198/4885RECQL 25/4885MAOB 1044/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.